Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEISH-F2 + MPL-SE vaccine for cutaneous leishmaniasis
NCT01011309Phase 2Completed
- Sponsor
- Access to Advanced Health Institute
- Start
- Oct 2009
- Primary completion
- May 2011
- Modality
- Vaccines & Immunotherapeutics, Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of LEISH-F2 + MPL-SE in cutaneous leishmaniasis (CL), sponsored by Access to Advanced Health Institute. Started Oct 2009; status: completed.
02
Drugs
LEISH-F2 + MPL-SE
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT01011309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01011309.